Medicon Hellas Statistics

Total Valuation

Medicon Hellas has a market cap or net worth of EUR 10.56 million. The enterprise value is 11.75 million.

Market Cap	10.56M
Enterprise Value	11.75M

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	Jul 15, 2024

Share Statistics

Medicon Hellas has 4.42 million shares outstanding.

Current Share Class	4.42M
Shares Outstanding	4.42M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.41%
Float	n/a

Valuation Ratios

The trailing PE ratio is 8.04.

PE Ratio	8.04
Forward PE	n/a
PS Ratio	0.58
PB Ratio	0.57
P/TBV Ratio	0.58
P/FCF Ratio	10.61
P/OCF Ratio	5.28
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.47, with an EV/FCF ratio of 11.80.

EV / Earnings	8.60
EV / Sales	0.65
EV / EBITDA	3.47
EV / EBIT	7.12
EV / FCF	11.80

Financial Position

The company has a current ratio of 5.49, with a Debt / Equity ratio of 0.51.

Current Ratio	5.49
Quick Ratio	4.65
Debt / Equity	0.51
Debt / EBITDA	2.79
Debt / FCF	9.48
Interest Coverage	2.84

Financial Efficiency

Return on equity (ROE) is 6.78% and return on invested capital (ROIC) is 3.66%.

Return on Equity (ROE)	6.78%
Return on Assets (ROA)	3.25%
Return on Invested Capital (ROIC)	3.66%
Return on Capital Employed (ROCE)	5.99%
Revenue Per Employee	115,442
Profits Per Employee	8,702
Employee Count	157
Asset Turnover	0.57
Inventory Turnover	1.70

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.90% in the last 52 weeks. The beta is 0.49, so Medicon Hellas's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	-16.90%
50-Day Moving Average	2.21
200-Day Moving Average	2.25
Relative Strength Index (RSI)	58.06
Average Volume (20 Days)	3,395

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicon Hellas had revenue of EUR 18.12 million and earned 1.37 million in profits. Earnings per share was 0.31.

Revenue	18.12M
Gross Profit	12.88M
Operating Income	1.65M
Pretax Income	1.42M
Net Income	1.37M
EBITDA	2.93M
EBIT	1.65M
Earnings Per Share (EPS)	0.31

Full Income Statement

Balance Sheet

The company has 8.51 million in cash and 9.44 million in debt, giving a net cash position of -927,420 or -0.21 per share.

Cash & Cash Equivalents	8.51M
Total Debt	9.44M
Net Cash	-927,420
Net Cash Per Share	-0.21
Equity (Book Value)	18.57M
Book Value Per Share	4.14
Working Capital	17.74M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.00 million and capital expenditures -1.01 million, giving a free cash flow of 995,407.

Operating Cash Flow	2.00M
Capital Expenditures	-1.01M
Free Cash Flow	995,407
FCF Per Share	0.23

Full Cash Flow Statement

Margins

Gross margin is 71.07%, with operating and profit margins of 9.10% and 7.54%.

Gross Margin	71.07%
Operating Margin	9.10%
Pretax Margin	7.81%
Profit Margin	7.54%
EBITDA Margin	16.16%
EBIT Margin	9.10%
FCF Margin	5.49%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 2.51%.

Dividend Per Share	0.06
Dividend Yield	2.51%
Dividend Growth (YoY)	-60.82%
Years of Dividend Growth	n/a
Payout Ratio	19.41%
Buyback Yield	n/a
Shareholder Yield	2.58%
Earnings Yield	12.93%
FCF Yield	9.42%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 28, 2004. It was a forward split with a ratio of 1.1.

Last Split Date	Jul 28, 2004
Split Type	Forward
Split Ratio	1.1

Scores

Medicon Hellas has an Altman Z-Score of 2.47. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.47
Piotroski F-Score	n/a